All Articles
Showing 25–36 of 155 articles.
Pooled Cohort and Trial Data Link Higher Weekly Resistance Training to Improved Insulin Sensitivity and Blood Pressure
Higher Resistance Training Volumes Linked to Modest Improvements in Cardiometabolic Risk Markers
Read More →FDA Warns of Adverse Events Linked to Unapproved Compounded Versions of GLP-1 Drugs
The Food and Drug Administration has updated its safety communications regarding compounded semaglutide. Officials…
Read More →What Primary Literature Shows About Plant-Based Eating Patterns and Prostate Cancer Risk in Men
Cohort data summarized by the National Cancer Institute show that men following plant-based eating patterns had lower…
Read More →Health Insurance to Buy for Individuals
Readers will gain a clear understanding of how to evaluate and select individual health insurance that aligns with…
Read More →FDA Clears Zepbound as New Option for Obesity Treatment
FDA Approves Zepbound (Tirzepatide) for Chronic Weight Management
Read More →FDA Clarifies Which Digital Wellness Tools Fall Under Medical Device Regulation
The FDA has spelled out more details on its oversight of digital health products. Its risk-based framework looks at…
Read More →Pooled Cohort and Trial Data Link Resistance Exercise to Higher Bone Density in Men over 50
Resistance Training Associated With Modest BMD Gains in Middle-Aged and Older Men
Read More →What Multiple Longitudinal Studies Show About Sleep and Hormonal Health in Men
Cohort Findings Link Short Sleep to Lower Testosterone and Cardiometabolic Risks in Middle-Aged Men
Read More →FDA Outlines Predetermined Change Control Plans for AI/ML-Based Cardiac Devices
FDA Updates Regulatory Expectations for AI-Enabled Cardiovascular Monitoring Devices
Read More →FDA Clears First OTC CGM Device for Diabetes Management and Prevention
FDA Clears First Over-the-Counter Continuous Glucose Monitor
Read More →FDA Outlines Regulatory Expectations for AI-Driven Heart Monitoring Wearables
FDA Draft Guidance Outlines Expectations for AI Wearables in Cardiovascular Risk Assessment
Read More →FDA Outlines New Regulatory Expectations for AI-Driven Cardiac Diagnostics and Remote Monitoring Tools
FDA Clarifies Path for Updates to AI Software Used in Heart Monitoring Devices
Read More →